163 related articles for article (PubMed ID: 17387473)
1. Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition.
Lang S; Tiwari S; Andratschke M; Loehr I; Lauffer L; Bergmann C; Mack B; Lebeau A; Moosmann A; Whiteside TL; Zeidler R
Cancer Immunol Immunother; 2007 Oct; 56(10):1645-52. PubMed ID: 17387473
[TBL] [Abstract][Full Text] [Related]
2. Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor.
Lang S; Lauffer L; Clausen C; Löhr I; Schmitt B; Hölzel D; Wollenberg B; Gires O; Kastenbauer E; Zeidler R
FASEB J; 2003 Feb; 17(2):286-8. PubMed ID: 12490541
[TBL] [Abstract][Full Text] [Related]
3. Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine.
Haas AR; Sun J; Vachani A; Wallace AF; Silverberg M; Kapoor V; Albelda SM
Clin Cancer Res; 2006 Jan; 12(1):214-22. PubMed ID: 16397045
[TBL] [Abstract][Full Text] [Related]
4. Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neck.
Cross DS; Platt JL; Juhn SK; Bach FH; Adams GL
Arch Otolaryngol Head Neck Surg; 1992 May; 118(5):526-8. PubMed ID: 1571128
[TBL] [Abstract][Full Text] [Related]
5. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma.
Bergmann C; Strauss L; Zeidler R; Lang S; Whiteside TL
Cancer Res; 2007 Sep; 67(18):8865-73. PubMed ID: 17875728
[TBL] [Abstract][Full Text] [Related]
6. Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.
Tas MP; Simons PJ; Balm FJ; Drexhage HA
Cancer Immunol Immunother; 1993; 36(2):108-14. PubMed ID: 8425208
[TBL] [Abstract][Full Text] [Related]
7. Restoration of dysregulated CC chemokine signaling for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity.
Chakraborty K; Bose A; Chakraborty T; Sarkar K; Goswami S; Pal S; Baral R
Cell Mol Immunol; 2010 Sep; 7(5):396-408. PubMed ID: 20622890
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lung cancer using clinically relevant oral doses of the cyclooxygenase-2 inhibitor rofecoxib: potential value as adjuvant therapy after surgery.
Tanaka T; Delong PA; Amin K; Henry A; Kruklitis R; Kapoor V; Kaiser LR; Albelda SM
Ann Surg; 2005 Jan; 241(1):168-78. PubMed ID: 15622005
[TBL] [Abstract][Full Text] [Related]
9. Expression of IL-10 and IL-10 receptors on peripheral blood lymphocytes and monocytes in human head and neck squamous cell carcinoma.
Kato H; Whiteside TL
Tokai J Exp Clin Med; 2011 Dec; 36(4):144-51. PubMed ID: 22167499
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
[TBL] [Abstract][Full Text] [Related]
13. Blockade of MCP-1/CCR4 signaling-induced recruitment of activated regulatory cells evokes an antitumor immune response in head and neck squamous cell carcinoma.
Sun W; Li WJ; Wei FQ; Wong TS; Lei WB; Zhu XL; Li J; Wen WP
Oncotarget; 2016 Jun; 7(25):37714-37727. PubMed ID: 27177223
[TBL] [Abstract][Full Text] [Related]
14. Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.
Kerrebijn JD; Simons PJ; Balm AJ; Tas M; Knegt PP; de Vries N; Tan IB; Drexhage HA
Head Neck; 1996; 18(4):335-42. PubMed ID: 8780944
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
16. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
18. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors.
Wang XM; Wu TX; Lee YS; Dionne RA
Clin Pharmacol Ther; 2006 Apr; 79(4):303-15. PubMed ID: 16580899
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
[TBL] [Abstract][Full Text] [Related]
20. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Nguyen N; Bellile E; Thomas D; McHugh J; Rozek L; Virani S; Peterson L; Carey TE; Walline H; Moyer J; Spector M; Perim D; Prince M; McLean S; Bradford CR; Taylor JM; Wolf GT;
Head Neck; 2016 Jul; 38(7):1074-84. PubMed ID: 26879675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
